DuPont de Nemours, Inc. filings document the regulatory disclosures of a Delaware specialty materials company with common stock listed on the New York Stock Exchange under DD. Its 8-K reports cover operating and financial results, Regulation FD disclosures, material events, board composition changes, corporate-governance matters and capital-structure disclosures.
DuPont proxy materials describe annual stockholder voting matters, director elections, governance practices, executive compensation and proposals affecting the company’s certificate of incorporation and common stock. Recent filings also document separation-related matters, including disclosures connected with the completed Qnity Electronics spin-off, as well as agreements and percentage calculations tied to the post-separation corporate structure.
DuPont de Nemours, Inc. director Edward D. Breen reported a Form 4 transaction showing a tax-related share withholding rather than an open-market trade. On this date, 7,567 shares of common stock were disposed of at $49.597 per share to satisfy taxes on lapsed restricted stock units and related dividend equivalent units. After this withholding transaction, Breen’s directly owned common stock holdings stood at 293,480.3495 shares.
DuPont de Nemours, Inc. Senior Vice President & CHRO Christopher Raia reported a tax-related share disposition. On February 15, 2026, 920 shares of common stock at $49.597 per share were withheld to cover taxes on lapsed RSUs and related dividend equivalents. After this withholding, he directly holds 79,334.5975 common shares.
DuPont de Nemours, Inc. CEO Lori Koch reported a tax-related share disposition tied to restricted stock units. On the reported date, 1,969 shares of common stock were withheld at a price of $49.597 per share to cover tax obligations on lapsed RSUs and related dividend equivalents. After this tax-withholding disposition, Koch directly held a remaining balance of 280,622.7321 DuPont common shares.
DuPont de Nemours, Inc. executive Erik T. Hoover, SVP & General Counsel, reported a tax-related share disposition. On February 15, 1,076 shares of common stock were withheld at $49.597 per share to cover taxes on lapsed RSUs and related dividend equivalents. After this withholding, he directly held 107,953.8355 shares.
DuPont de Nemours SVP & CFO Antonella B. Franzen reported a tax-related share disposition. On the reported date, 148 shares of common stock, valued at $49.597 per share, were withheld to cover taxes on lapsed restricted stock units and related dividend equivalents. After this withholding, she directly holds about 52,153.8169 common shares.
DuPont de Nemours, Inc. reported that officer Bloemhard Jeroen disposed of 259 shares of common stock at $49.597 per share to cover taxes on lapsed restricted stock units and related dividend equivalents. Following this tax-withholding disposition, his directly held stake stands at 15,879.6115 shares of DuPont common stock.
DuPont de Nemours, Inc. uses this 10-K to describe its transformation into a focused advanced solutions company serving healthcare, water, construction and industrial markets. The company operates globally in about 50 countries with manufacturing in about 20 countries.
DuPont completed the spin-off of its semiconductor and interconnect solutions businesses as Qnity Electronics in November 2025, treating Qnity, prior M&M divestitures and the planned Aramids sale as discontinued operations. Segment reporting was realigned into Healthcare & Water Technologies and Diversified Industrials, each built around branded materials and engineered solutions.
The filing highlights acquisitions such as Spectrum Plastics, Donatelle and Sinochem to deepen medical and water technologies, a $2 billion share repurchase authorization with a $500 million ASR, and extensive risk disclosures around complex tax and indemnity arrangements, PFAS cost-sharing, supply chains, regulation, cybersecurity and global economic and trade exposure.
DuPont de Nemours reported flat fourth-quarter 2025 net sales of $1.7 billion, with organic sales down 1% after a timing shift from system cut-over activities. The quarter showed a GAAP loss from continuing operations of $108 million, but operating EBITDA rose 4% to $409 million and adjusted EPS increased to $0.46 from $0.39. Transaction-adjusted free cash flow reached $228 million.
For full year 2025, net sales grew 2% to $6.8 billion, led by 7% organic growth in Healthcare & Water Technologies, partly offset by declines in Diversified Industrials. GAAP income from continuing operations was $98 million versus a prior-year loss, while operating EBITDA rose to $1.63 billion and adjusted EPS climbed 16% to $1.68. Transaction-adjusted free cash flow was $689 million.
The company completed the separation of its Electronics business into Qnity Electronics and is progressing on the planned Aramids divestiture, expected to close around the end of first-quarter 2026. For 2026, DuPont guides to net sales of $7.075–$7.135 billion, operating EBITDA of $1.725–$1.755 billion, and adjusted EPS of $2.25–$2.30, implying continued margin strength and earnings growth.
DuPont de Nemours, Inc. director Donald G. Macpherson filed an initial Form 3 reporting his beneficial ownership. As of the event date of January 20, 2026, he reports beneficial ownership of 0 shares of DuPont common stock, held directly.
DuPont de Nemours, Inc. reported that its Board of Directors has appointed D.G. Macpherson to the Board, effective immediately as of January 20, 2026. The Board determined that he qualifies as an independent director under New York Stock Exchange standards, SEC rules, and the company’s Corporate Governance Guidelines.
Macpherson, age 58, is the Chief Executive Officer and Chairman of W.W. Grainger, Inc., having served as CEO since 2016 and Chairman since 2017, following earlier senior operating roles at Grainger. His background also includes leadership at Boston Consulting Group and engineering experience in the U.S. Air Force, supported by degrees from Stanford University and Northwestern’s Kellogg School of Management.
DuPont stated there is no special arrangement or understanding under which he was selected and no related-party transactions requiring disclosure. He will receive DuPont’s standard compensation for non-employee directors. A press release announcing his appointment is included as Exhibit 99.1.